Drugs for the Treatment of Respiratory DiseasesDomenico Spina Cambridge University Press, 30 ene 2003 - 599 páginas Respiratory diseases affect millions of people each year and represent a major health burden around the world. This timely reference surveys and evaluates the drug treatments available for the main categories of lung diseases including asthma, tuberculosis, chronic obstructive pulmonary disease, lung cancer, and respiratory infections. The recent re-emergence of tuberculosis and the increase in asthma in certain populations underlines the importance of finding effective new treatments for these diseases. This publication, a comprehensive reference, is one of the first to survey current and novel drug treatments for this group of diseases. It is certain to establish itself as an essential source of reference for respiratory physicians, clinicians and clinical pharmacologists. |
Índice
Badrenoceptor agonists 56 | 56 |
Antiallergic drugs | 119 |
Theophylline and selective | 136 |
Potential therapeutic effects of | 172 |
Tachykinin and kinin antagonists | 184 |
Drugs affecting IgE synthesis inhibitors | 195 |
11 | 208 |
Diffuse parenchymal lung disease | 480 |
21 | 524 |
14 | 536 |
16 | 567 |
Otras ediciones - Ver todo
Términos y frases comunes
activity acute adrenoceptor aeruginosa agents agonists airway smooth muscle allergen Allergy Clin Immunol alveolar antagonist antibiotics artery associated asthma asthmatic subjects B₂-adrenoceptor Barnes PJ Biol biopsies bron bronchial bronchiectasis bronchoconstriction bronchodilator bronchoprotection budesonide chemotherapy Chest chronic obstructive pulmonary clinical COPD cough cystic fibrosis cytokines demonstrated drugs effects of inhaled efficacy emphysema endothelial eosinophils epithelium exacerbations factor fenoterol fibroblasts formoterol gene high dose histamine improvement increased induced infection inflammation inflammatory cells inhaled corticosteroids inhibition inhibitors interstitial intravenous ipratropium lesions leukotriene lung cancer lung disease lung function lymphocytes macrophages mast cells mediators ment mild neutrophils obstructive pulmonary disease oral patients PDE4 Pharmacol phosphodiesterase plasma pneumonia primary pulmonary hypertension prostacyclin pulmonary fibrosis pulmonary vascular receptor reduced regular treatment release Respir Crit respiratory response Rev Respir role salbutamol salmeterol sarcoidosis side effects smokers smooth muscle sputum studies symptoms terbutaline theophylline therapy Thorax tion tissue vasodilator vitro